Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$36.95 - $82.41 $122,378 - $272,941
-3,312 Closed
0 $0
Q3 2021

Nov 01, 2021

SELL
$145.58 - $192.14 $482,160 - $636,367
-3,312 Reduced 50.0%
3,312 $490,000
Q3 2021

Nov 01, 2021

BUY
$145.58 - $192.14 $482,160 - $636,367
3,312 Added 100.0%
6,624 $964,000
Q4 2020

Feb 12, 2021

BUY
$126.47 - $163.7 $418,868 - $542,174
3,312 New
3,312 $469,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.39B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.